![]() |
市場調査レポート
商品コード
1447137
脊椎椎弓形成術の2030年までの市場予測:手術タイプ別、材料別、脊椎骨位置別、技術別、エンドユーザー別、地域別の世界分析Spinal Laminoplasty Market Forecasts to 2030 - Global Analysis By Surgery Type, By Material (Polyetheretherketone Implants, Titanium Implants and Tantalum Implants), Vertebral Position, Technology, End User and By Geography |
||||||
カスタマイズ可能
|
脊椎椎弓形成術の2030年までの市場予測:手術タイプ別、材料別、脊椎骨位置別、技術別、エンドユーザー別、地域別の世界分析 |
出版日: 2024年03月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
|
Stratistics MRCによると、脊椎椎弓形成術の世界市場は2023年に59億8,000万米ドルを占め、予測期間中にCAGR 5.5%で成長し、2030年には87億1,000万米ドルに達すると予測されています。
脊椎椎弓形成術は、脊柱管を拡大することによって頸部脊柱管狭窄症を治療するために使用される外科的処置です。ラミナ骨の片側にヒンジを作って持ち上げ、脊髄と神経の減圧を可能にします。この方法は脊髄の安定性を保ちながら、脊髄の圧迫による痛み、しびれ、脱力感などの症状を緩和します。
2021年に発表された研究によると、米国では約50万件の腰椎手術が行われました。
脊柱管狭窄症の有病率の上昇
脊柱管狭窄症の有病率の上昇は、脊椎椎弓形成術市場の重要な促進要因となっています。脊柱管狭窄症は脊柱管の狭窄を特徴とし、脊髄や神経の圧迫につながり、痛み、しびれ、脱力感などの症状を引き起こします。脊髄の圧迫を緩和することを目的とした外科手術である脊椎椎弓形成術は、脊柱管狭窄症患者の治療オプションとして採用されることが増えています。このような患者数の増加が、椎弓形成術や関連医療機器の需要を促進し、市場の成長を促しています。
高額な処置費用
患者は、特にヘルスケア保険が限られている地域や自己負担額が高い地域では、治療を受ける際に経済的な障壁に直面する可能性があります。さらに、ヘルスケアプロバイダーや施設は、支払者との償還や価格交渉において課題に直面する可能性があり、手頃な価格のサービスを提供する能力に影響を与えます。このような費用の障壁は、患者が治療を求めたり完了したりすることを躊躇させ、脊椎椎弓形成術の全体的な市場可能性を制限することになります。
低侵襲手術に対する認識の高まり
低侵襲手術は、従来の開腹手術と比較して、術後疼痛の軽減、入院期間の短縮、回復時間の短縮などの利点があります。こうした利点について患者が知識を深めるにつれ、椎弓形成術を含む低侵襲脊椎手術に対する需要が高まっています。この動向は手術技術や手技の革新を促し、ヘルスケアプロバイダーが低侵襲アプローチを採用し、脊椎椎弓形成術市場で提供する製品を拡大することを後押ししています。
脊椎椎弓形成術に伴う合併症
脊椎椎弓形成術に伴う合併症は、市場に大きな脅威を与えています。神経損傷、感染症、脊椎の不安定性を含むこれらの合併症は、術後の合併症や患者の不満足につながる可能性があります。さらに、再手術や長期的な合併症のリスクは、患者や医療提供者の両方が層形成術を治療オプションとして選択することを躊躇させる可能性があります。さらに、否定的な結果は、手技の評判を損ない、その採用率を低下させ、脊椎椎弓形成術市場の成長見通しに影響を与える可能性があります。
COVID-19の流行は、選択的手術を中断させ、ヘルスケア施設への患者のアクセスを減少させることで、脊椎椎弓形成術市場に影響を与えています。封鎖措置とパンデミック管理へのリソースの再配分は、緊急でない脊椎手術の延期につながった。その結果、脊椎椎弓形成術サービスを提供するヘルスケアプロバイダーの手術件数と収益が減少しました。
予測期間中、開放型椎弓形成術分野が最大となる見込み
予測期間中、脊椎椎弓形成術市場は開腹による椎弓形成術が主流になると予想されます。これは、開腹による椎弓形成術が長年使用され、確立された手術手技であることに起因しています。さらに、開腹による椎弓形成術は、低侵襲技術と比較して、脊髄の可視化と減圧が可能です。さらに、外科医が慣れ親しんだ実績のある手術方法を好むことも、脊椎外科における開腹椎弓形成術の持続的な需要に寄与しています。
予測期間中、3Dプリンティング分野のCAGRが最も高くなると予測される
3Dプリンティング分野は、予測期間中、脊椎椎弓形成術市場で最も高い成長率を示すと予測されています。この成長の原動力は、3Dプリンティング技術の進歩により、個々の解剖学的構造に合わせた患者固有のインプラントや手術器具の製造が可能になったことです。さらに、3Dプリンティングは、手術精度の向上、製造時間の短縮、コストの削減などの特典を提供します。これらの要因が、脊椎椎弓形成術における3Dプリンティングの採用拡大に寄与し、市場の成長を促進しています。
北米は、先進的なヘルスケアインフラ、脊椎疾患の高い有病率、革新的な医療技術の早期導入により、脊椎椎弓形成術市場で最大の市場シェアを確保しています。さらに、強固な償還政策と有利なヘルスケア規制が、北米における脊椎手術の普及を支えています。さらに、大手医療機器企業や有名ヘルスケア機関の存在が、脊椎椎弓形成術市場における同地域の優位性をさらに強めています。
アジア太平洋地域は、脊椎疾患の有病率の増加、医療費の増加、高度医療施設へのアクセスの拡大により、脊椎椎弓形成術市場の急成長が見込まれています。さらに、ヘルスケアインフラの改善や脊椎の健康に対する意識の高まりが、脊椎椎弓形成術のような外科的介入に対する需要を促進しています。さらに、この地域の人口の多さと高齢化により、多くの患者が存在し、アジア太平洋市場における脊椎手術の成長機会に寄与しています。
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
According to Stratistics MRC, the Global Spinal Laminoplasty Market is accounted for $5.98 billion in 2023 and is expected to reach $8.71 billion by 2030 growing at a CAGR of 5.5% during the forecast period. Spinal laminoplasty is a surgical procedure used to treat cervical spinal stenosis by enlarging the spinal canal. It involves creating a hinge on one side of the lamina bone and lifting it, allowing decompression of the spinal cord and nerves. This technique preserves spinal stability while providing relief from symptoms such as pain, numbness, and weakness caused by spinal cord compression.
According to a study published in 2021, approximately 500,000 lumbar spine surgeries were performed in the US.
Rising prevalence of spinal stenosis
The rising prevalence of spinal stenosis serves as a significant driver in the spinal laminoplasty market. Spinal stenosis, characterized by the narrowing of the spinal canal, leads to compression of the spinal cord and nerves, causing symptoms like pain, numbness, and weakness. Spinal laminoplasty, a surgical procedure aimed at alleviating spinal cord compression, is increasingly adopted as a treatment option for patients with spinal stenosis. This growing patient population drives demand for laminoplasty procedures and related medical devices, fostering market growth.
High cost of procedures
Patients may face financial barriers to accessing treatment, especially in regions with limited healthcare coverage or high out-of-pocket expenses. Additionally, healthcare providers and facilities may experience challenges in reimbursement and pricing negotiations with payers, impacting their ability to offer affordable services. This cost barrier can deter patients from seeking or completing treatment, thereby limiting the overall market potential for spinal laminoplasty procedures.
Growing awareness of minimally invasive surgeries
Minimally invasive techniques offer advantages such as reduced post-operative pain, shorter hospital stays, and quicker recovery times compared to traditional open surgeries. As patients become more informed about these benefits, there is a rising demand for minimally invasive spinal procedures, including laminoplasty. This trend drives innovation in surgical technologies and techniques, encouraging healthcare providers to adopt minimally invasive approaches and expand their offerings in the spinal laminoplasty market.
Complications associated with spinal laminoplasty
The complications associated with spinal laminoplasty pose a significant threat to the market. These complications, including nerve damage, infection, and instability of the spine, can lead to post-operative complications and patient dissatisfaction. Moreover, the risk of reoperation and long-term complications may deter both patients and healthcare providers from choosing laminoplasty as a treatment option. Additionally, negative outcomes can damage the reputation of the procedure and decrease its adoption rate, impacting the growth prospects of the spinal laminoplasty market.
The COVID-19 pandemic has impacted the spinal laminoplasty market by disrupting elective surgeries and reducing patient access to healthcare facilities. Lockdown measures and reallocation of resources towards managing the pandemic led to the postponement of non-urgent spinal procedures. This resulted in decreased procedural volumes and revenue for healthcare providers offering spinal laminoplasty services.
The open laminoplasty segment is expected to be the largest during the forecast period
Over the forecast period, the open laminoplasty segment is anticipated to dominate the spinal laminoplasty market. This is attributed to the long-standing use of and established surgical techniques associated with open laminoplasty procedures. Additionally, open laminoplasty allows for greater visualization and decompression of the spinal cord compared to minimally invasive techniques. Furthermore, the preference for familiar and proven surgical methods by surgeons contributes to the sustained demand for open laminoplasty procedures in spinal surgery.
The 3D printing segment is expected to have the highest CAGR during the forecast period
The 3D printing segment is projected to witness the highest growth rate in the spinal laminoplasty market during the forecast period. This growth is driven by advancements in 3D printing technology, enabling the production of patient-specific implants and surgical instruments tailored to individual anatomies. Additionally, 3D printing offers benefits such as improved surgical precision, faster production times, and reduced costs. These factors contribute to the increasing adoption of 3D printing in spinal laminoplasty procedures, fueling market growth.
North America is positioned to secure the largest market share in the spinal laminoplasty market due to the region's advanced healthcare infrastructure, high prevalence of spinal disorders, and early adoption of innovative medical technologies. Additionally, robust reimbursement policies and favorable healthcare regulations support the uptake of spinal procedures in North America. Moreover, the presence of leading medical device companies and renowned healthcare institutions further strengthens the region's dominance in the spinal laminoplasty market.
The Asia-Pacific region is poised for rapid growth in the spinal laminoplasty market owing to the increasing prevalence of spinal disorders, rising healthcare expenditures, and expanding access to advanced medical facilities. Additionally, improving healthcare infrastructure and growing awareness about spinal health drive demand for surgical interventions like laminoplasty. Moreover, the region's large population and aging demographics create a substantial patient pool, contributing to the growth opportunities for spinal procedures in the Asia-Pacific market.
Key players in the market
Some of the key players in Spinal Laminoplasty Market include Aesculap, Inc., Alphatec Holdings, Inc., Amedica Corporation, Captiva Spine, CoreLink, LLC, DePuy Synthes, Globus Medical Inc., Joimax GmbH, Medtronic plc, Nexxt Spine LLC, NuVasive, Inc., Orthofix Medical Inc., Osseus Fusion Systems, RTI Surgical Holdings, Inc., Spinal Elements, Inc., Spineart, Stryker Corporation, Ulrich Medical and Zimmer Biomet Holdings, Inc.
In October 2023, Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TriLEAP(TM) Lower Extremity Anatomic Plating System, a comprehensive yet modular, procedure-specific system designed to meet the complex needs of orthopaedic surgeons, doctors of podiatric medicine, and foot and ankle specialists. The TriLEAP(TM) System provides a diverse offering of contoured and conventional plates that can accommodate multiple screw diameters, and instruments that can be used during the reduction, internal fixation and fusion of bones and bone fragments.
In September 2023, Globus Medical, Inc., a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc. The combined company will provide surgeons and patients with one of the most comprehensive offerings of musculoskeletal procedural solutions and enabling technologies to impact the care continuum.
In December 2022, Captiva Spine announces an exclusive strategic partnership with REMEX Medical for Spine Navigation and Robotics, adding to their expanding product portfolio. For underserved hospitals and Ambulatory Surgery Centers (ASCs) throughout the U.S., this technology will serve as a platform to expand the company's products and services with enhanced enabling technology to support MIS technology. Specifically, Captiva Spine will be starting with their CapLOX Pedicle Screws, TowerLOX-EXT MIS Extended Tab Pedicle Screws, and TransFasten Posterior SI joint fusion system.